Novel amino derivatives and carboxamides of chromen-2-one were synthesized and evaluated for antimicrobial activity. Compound 9 showed potent antifungal effects, while compounds 10 and 13 were active against the bacteria. Docking studies revealed strong bindng to sterol-14α demethylase and peptide deformylase, supported by multiple sequence alignment analysis.

Abstract

In this study, a series of novel amino derivatives and carboxamides of chromen-2-one were synthesized and screened for their antimicrobial efficacy. Among these, compound 9 was found to be active against all pathogenic Aspergilli and exhibited a minimum inhibitory concentration (MIC) of 15.62 - 31.25 µg/mL in microbroth dilution assay (MDA) and 3.91 µg/disc in disc diffusion assay (DDA). Further, compounds 10 and 13 were found to be active against pathogenic bacteria up to 1.90 µg/disc in DDA. All these active compounds were non-toxic to human erythrocytes up to 1000 µg/mL, whereas the standard drug Amphotericin B lysed all cells at 37.50 µg/mL. The interaction with these antimicrobial results was stimulated by a molecular docking study against the sterol-14 alpha demethylase for Aspergillus fumigatus (PDB ID - 5FRB) and the peptide deformylase for Pseudomonas aeruginosa (PDB ID - 1LRY). Docking showed that compounds 9, 10, and 13 exerted the strongest docking binding values against these proteins. The consistency of the binding affinity was studied using multiple sequence alignment (MSA).